FindTrial
Sign In

Combination of traditional Chinese medicine and western medicine in the treatment of COVID-19: a real-world efficacy evaluation study

Real world study on standardized clinical database establishment and treatment plan development for severe or critical COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062917
Enrollment
Unknown
Registered
2022-08-23
Start date
2022-09-05
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

TCM group:TCM treatment group

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Confirmed diagnosis COVID-19. (2) Age >=18 years old. (3) The interval between the onset of symptoms and hospitalization was within 14 days.

Exclusion criteria

Exclusion criteria: (1) Not the first time infected with COVID-19. (2) Participated in other interventional clinical trials. (3) Etiological evidence shows that the patient has pneumonia caused by other pathogens (not SARS-CoV-2). (4) Death within 48 hours of admission.

Design outcomes

Primary

MeasureTime frame
Incidence of composite events;—

Secondary

MeasureTime frame
mortality;—

Countries

China

Contacts

Public ContactQingquan Liu

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

liuqingquan2003@126.com13910055687

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026